The Tip of the Iceberg: Pathway Biology Must Anchor the Next Generation of Critical Care Trials
{{output}}
Heterogeneity of treatment effect has yielded decades of negative critical care trials. Syndromic diagnoses like sepsis and acute respiratory distress syndrome mask distinct molecular programs that respond differently to the same intervention, and single bioma... ...
